CD8A and cancer: A current notion is that immunosurveillance of newly generated cancer cells and their metastatic dissemination from a primary tumor is mediated by the innate immunity effectors, NK cells, while control of tumor growth is mediated by the adaptive immunity effectors, tumor-specific CD8+ cytotoxic T lymphocytes (CTLs) (28, 29).